Slide 1Management of Multiple Myeloma Irza Wahid Subdivision of Hematology – Medical Oncology Departement of Internal Medicine Medical Faculty, Andalas University Slide…
Slide 1 Slide 2 Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological…
Slide 1 The Non-Leukaemic Lymphoproliferative Disorders Ahmad Sh. Silmi Msc Hematology, FIBMS IUG Slide 2 The Non-Leukaemic Lymphoproliferative Disorders These are malignant…
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein) Incidence:…
SAR650984, a CD38 Monoclonal Antibody in Patients with Selected CD38+ Hematological Malignancies â Data from a Dose-Escalation Phase I Study Martin TG et al. Proc ASH 2013;Abstract…
SAR650984, a CD38 Monoclonal Antibody in Patients with Selected CD38+ Hematological Malignancies â Data from a Dose-Escalation Phase I Study Martin TG et al. Proc ASH 2013;Abstract…
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin ( M protein ). Incidence:…
Multiple myeloma: 2020 update on diagnosis, riskstratification and managementANNUA L C L I N I C A L U P DA T E S I N H EMA TO LOG I C A L MA L I G N AN C I E S Multiple